I. Today's Presentation and References |
View |
Download |
Download an Archive of Today's Seminar For
Future Reference |
|
|
II. Additional Resources |
View |
Download |
U.S. EPA's PPCPs Web Site |
| |
Pharmaceuticals
in the Environment Brochure (108K/1p/PDF) | |
|
PharmWaste Listserve |
| |
C. Daughton. 2005. "Emerging" Chemicals as Pollutants in the Environment: a 21st Century. Renewable Resources Journal 23 (4):6-23. |
| |
B. Schwab, E. Hayes, J. Fiori, F. Mastrocco, N. Roden, D, Cragin, R. Meyerhoff, V. D�Aco, P. Anderson. 2005. Human pharmaceuticals in US surface waters: A human health risk assessment. Regulatory Toxicology and Pharmacology 42: 296-312. |
| |
V. Cunningham, M. Buzby, T. Hutchinson, F. Mastrocco, N. Parke, N. Roden. 2006. Effects of Human Pharmaceuticals on Aquatic Life: Next Steps. Environmental Science & Technology (June) 3457 -3462. |
| |
P. Anderson, V. D�Aco, P. Shanahan, S. Chapra, M. Buzby, V. Cunningham, B. Duplessie, E. Hayes, F. Mastrocco, N. Parke, J. Rader, J. Samuelian, B. Schwab. 2004. Screening Analysis of Human Pharmaceutical Compounds in U.S. Surface Waters. Environmental Science & Technology 38 (3): 838-849. |
| |
N. Nakada, H. Nyunoya, M. Nakamura, A. Hara, T. Iguchi, H. Takada. 2004. Identification of Estrogenic Compounds in Wastewater Effluent. Environmental Toxicology and Chemistry 23 (12): 2807-2815. |
| |
T. Luckenbach, D. Epel. 2005. Nitromusk and Polycyclic Musk Compounds as Long-Term Inhibitors of Cellular Xenobiotic Defense Systems Mediated by Multidrug Transporters. 2005. Environmental Health Perspectives. 113 (1): 17-24. |
| |
Glassmeyer S.T., E.T. Furlong, D.W. Kolpin, J.D. Cahill, S.D. Zaugg,
S.L. Werner, M.T. Meyer, and D.D. Kryak. 2005. Transport of chemical
and microbial compounds from known wastewater discharges: Potential
for use as indicators of human fecal contamination. Environmental
Science and Technology. 39:5157-5169. |
| |
Glassmeyer, S.T., and J.A. Shoemaker. 2005. Effects of chlorination
on the persistence of pharmaceuticals in the environment. Bulletin of
Environmental Contamination and Toxicology. 74:24-31. |
| |
III. Additional Resources from Part 1: Pharmaceuticals in the Environment
and What's Happening in the EPA Regions |
View |
Download |
Pharmaceuticals in the Environment:
Overview of Sources, Concerns, and Solutions (Abstract, 32K/1p/PDF) |
| |
Daughton 2001 "Illicit Drugs in Municipal Sewage: Proposed New Non-Intrusive Tool to Heighten Public Awareness of Societal Use of Illicit/Abused Drugs and Their Potential for Ecological Consequences," in C.G. Daughton and T.L. Jones-Lepp (Editors), Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues, Symposium Series 791, American Chemical Society: Washington, D.C., 2001, pp. 348-364 |
| |
Origins and Fate of PPCPs in the Environment |
| |
J. J. Johnston et al. "Risk Assessment of an Acetaminophen Baiting
Program for Chemical Control of Brown Tree Snakes on Guam: Evaluation
of Baits, Snake Residues, and Potential Primary and Secondary Hazards,"
Environ. Sci. Technol. 2002, 36(17):3827-3833 |
| |
"Environmental Warning Added to Animal Euthanasia Products," U.S. FDA, Center for Veterinary Medicine Update, 22 July 2003 |
| |
Mercury in Skin Lightening Soaps and Creams
|
NYC Health Dept. Warns Against Use of "Skin-Lightening" Creams Containing Mercury or Similar Products Which Do Not List Ingredients |
| |
Fact Sheet: Mercury in Skin Lightening Soaps and Creams |
| |
Presentation: Mercury in Soaps and Cosmetics for Skin Lightening |
| |
A World of Salt: Total Global Saltwater and Freshwater Estimates |
| |
Daughton C.G. "Groundwater Recharge and Chemical Contaminants: Challenges in Communicating the Connections and Collisions of Two Disparate Worlds," In Fate and Transport of Pharmaceuticals and Endocrine Disrupting Compounds (EDCs) During Ground Water Recharge (special issue), Ground Water Monitoring & Remediation, 2004, 24(2): 127-138. |
| |
How should unwanted/unneeded
medications be disposed?
|
| |
Molecular Expressions, Florida State University
|
| |
Drinking Water Contaminant Candidate List (CCL)
|
| |
IV. Additional Resources from Part 2: Prioritizing Pharmaceuticals for Study using Bioinformatics Approaches
and Identifying Chemical Compounds from Wastewater Discharges |
View |
Download |
To be inserted
|
V. Additional Resources from Part 3: Wastewater Treatment Plant Perspectives: Preliminary Data Suggesting
Endocrine Disrupting Effects of Discharge to the Pacific Ocean
and Endocrine Effects of Selective Serotonin Reuptake Inhibitors (SSRIs) on Aquatic Organisms |
View |
Download |
Orange County Sanitation District
|
| |
Thyroid illustration
|
| |
VI. Additional Resources from Part 4: Hospitals for a Healthy Environment (H2E) �Helping to Reduce Pharmaceuticals in Water
and Highlights and Lessons Learned from the 2006 Regional
Pharmaceutical Take-Back Event in the San Francisco Bay Area |
View |
Download |
To be inserted
|
VII. Rebroadcast of Other Internet Seminars and Training
Opportunities |
View |
Download |
See the CLU-IN Studio for
announcements of upcoming seminars and the archives of past
seminars |
|
|
Subscribe to the TechDirect
ListServ and be notified of future unrestricted Internet seminars |
|
|